238 related articles for article (PubMed ID: 32272787)
1. Conformational Characterization of Native and L17A/F19A-Substituted Dutch-Type β-Amyloid Peptides.
He KC; Chen YR; Liang CT; Huang SJ; Tzeng CY; Chang CF; Huang SJ; Huang HB; Lin TH
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32272787
[TBL] [Abstract][Full Text] [Related]
2. Effect of alanine replacement of l17 and f19 on the aggregation and neurotoxicity of arctic-type aβ40.
Chen YR; Huang HB; Lo CJ; Wang CC; Ho LK; Liu HT; Shiao MS; Lin TH; Chen YC
PLoS One; 2013; 8(4):e61874. PubMed ID: 23634215
[TBL] [Abstract][Full Text] [Related]
3. Molecular insights into the effect L17A/F19A double mutation on the structure and dynamics of Aβ
Saini RK; Shuaib S; Goyal D; Goyal B
J Cell Biochem; 2018 Nov; 119(11):8949-8961. PubMed ID: 30076733
[TBL] [Abstract][Full Text] [Related]
4. L17A/F19A Substitutions Augment the α-Helicity of β-Amyloid Peptide Discordant Segment.
Liang CT; Huang HB; Wang CC; Chen YR; Chang CF; Shiao MS; Chen YC; Lin TH
PLoS One; 2016; 11(4):e0154327. PubMed ID: 27104649
[TBL] [Abstract][Full Text] [Related]
5. The Arctic mutation accelerates Aβ aggregation in SDS through reducing the helical propensity of residues 15-25.
Lo CJ; Wang CC; Huang HB; Chang CF; Shiao MS; Chen YC; Lin TH
Amyloid; 2015 Mar; 22(1):8-18. PubMed ID: 25376379
[TBL] [Abstract][Full Text] [Related]
6. Aβ40(L17A/F19A) mutant diminishes the aggregation and neurotoxicity of Aβ40.
Chen YR; Huang HB; Lo CJ; Wang CC; Su CL; Liu HT; Shiao MS; Lin TH; Chen YC
Biochem Biophys Res Commun; 2011 Feb; 405(1):91-5. PubMed ID: 21216230
[TBL] [Abstract][Full Text] [Related]
7. Charge states rather than propensity for beta-structure determine enhanced fibrillogenesis in wild-type Alzheimer's beta-amyloid peptide compared to E22Q Dutch mutant.
Massi F; Klimov D; Thirumalai D; Straub JE
Protein Sci; 2002 Jul; 11(7):1639-47. PubMed ID: 12070316
[TBL] [Abstract][Full Text] [Related]
8. Role of the familial Dutch mutation E22Q in the folding and aggregation of the 15-28 fragment of the Alzheimer amyloid-beta protein.
Baumketner A; Krone MG; Shea JE
Proc Natl Acad Sci U S A; 2008 Apr; 105(16):6027-32. PubMed ID: 18408165
[TBL] [Abstract][Full Text] [Related]
9. Neurotoxicity and physicochemical properties of Abeta mutant peptides from cerebral amyloid angiopathy: implication for the pathogenesis of cerebral amyloid angiopathy and Alzheimer's disease.
Murakami K; Irie K; Morimoto A; Ohigashi H; Shindo M; Nagao M; Shimizu T; Shirasawa T
J Biol Chem; 2003 Nov; 278(46):46179-87. PubMed ID: 12944403
[TBL] [Abstract][Full Text] [Related]
10. Anti-Parallel β-Hairpin Structure in Soluble Aβ Oligomers of Aβ40-Dutch and Aβ40-Iowa.
Fu Z; Van Nostrand WE; Smith SO
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513738
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the aggregation properties, secondary structure and apoptotic effects of wild-type, Flemish and Dutch N-terminally truncated amyloid beta peptides.
Demeester N; Mertens C; Caster H; Goethals M; Vandekerckhove J; Rosseneu M; Labeur C
Eur J Neurosci; 2001 Jun; 13(11):2015-24. PubMed ID: 11422442
[TBL] [Abstract][Full Text] [Related]
12. Aggregation and catabolism of disease-associated intra-Abeta mutations: reduced proteolysis of AbetaA21G by neprilysin.
Betts V; Leissring MA; Dolios G; Wang R; Selkoe DJ; Walsh DM
Neurobiol Dis; 2008 Sep; 31(3):442-50. PubMed ID: 18602473
[TBL] [Abstract][Full Text] [Related]
13. Insights into Cerebral Amyloid Angiopathy Type 1 and Type 2 from Comparisons of the Fibrillar Assembly and Stability of the Aβ40-Iowa and Aβ40-Dutch Peptides.
Rajpoot J; Crooks EJ; Irizarry BA; Amundson A; Van Nostrand WE; Smith SO
Biochemistry; 2022 Jun; 61(12):1181-1198. PubMed ID: 35666749
[TBL] [Abstract][Full Text] [Related]
14. Structural heterogeneity in familial Alzheimer's disease mutants of amyloid-beta peptides.
Chong SH; Yim J; Ham S
Mol Biosyst; 2013 May; 9(5):997-1003. PubMed ID: 23358498
[TBL] [Abstract][Full Text] [Related]
15. Effects of the Arctic (E22-->G) mutation on amyloid beta-protein folding: discrete molecular dynamics study.
Lam AR; Teplow DB; Stanley HE; Urbanc B
J Am Chem Soc; 2008 Dec; 130(51):17413-22. PubMed ID: 19053400
[TBL] [Abstract][Full Text] [Related]
16. The structures of the E22Δ mutant-type amyloid-β alloforms and the impact of E22Δ mutation on the structures of the wild-type amyloid-β alloforms.
Coskuner O; Wise-Scira O; Perry G; Kitahara T
ACS Chem Neurosci; 2013 Feb; 4(2):310-20. PubMed ID: 23421682
[TBL] [Abstract][Full Text] [Related]
17. Familial Alzheimer's disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system.
Tackenberg C; Kulic L; Nitsch RM
PLoS One; 2020; 15(9):e0239584. PubMed ID: 32966331
[TBL] [Abstract][Full Text] [Related]
18. Pathogenic effects of D23N Iowa mutant amyloid beta -protein.
Van Nostrand WE; Melchor JP; Cho HS; Greenberg SM; Rebeck GW
J Biol Chem; 2001 Aug; 276(35):32860-6. PubMed ID: 11441013
[TBL] [Abstract][Full Text] [Related]
19. Amyloid beta(1-42) in aqueous environments: effects of ionic strength and E22Q (Dutch) mutation.
Bossis F; Palese LL
Biochim Biophys Acta; 2013 Dec; 1834(12):2486-93. PubMed ID: 24016775
[TBL] [Abstract][Full Text] [Related]
20. Influence of the familial Alzheimer's disease-associated T43I mutation on the transmembrane structure and γ-secretase processing of the C99 peptide.
Tang TC; Kienlen-Campard P; Hu Y; Perrin F; Opsomer R; Octave JN; Constantinescu SN; Smith SO
J Biol Chem; 2019 Apr; 294(15):5854-5866. PubMed ID: 30755484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
